Skip to content


Crixivan (indinavir) is a small molecule pharmaceutical. Indinavir was first approved as Crixivan on 1996-03-13. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections. Crixivan's patent is valid until 2021-02-10 (FDA).
Trade Name Crixivan
Common Name Indinavir
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Antivirals: HIV protease inhibitors (saquinavir type)
Get full access now